| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $310.5M | +47.0% |
| Cost of Revenue | $189.9M | +53.7% |
| Gross Profit | $120.6M | +37.5% |
| R&D Expense | $15.8M | +86.5% |
| SG&A Expense | $106.0M | +63.7% |
| Operating Income | -$21.0M | — |
| Pre-tax Income | -$20.5M | -734.1% |
| Income Tax | $8.8M | +66.9% |
| Net Income | -$29.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $256.7M | +77.8% |
| Accounts Receivable | $48.4M | +24.5% |
| Current Assets | $323.1M | +67.6% |
| Total Assets | $411.1M | +60.2% |
| Current Liabilities | $38.7M | +52.7% |
| Total Liabilities | $48.1M | +62.1% |
| Stockholders' Equity | $363.0M | +59.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $31.7M | +76.1% |
| Capital Expenditures | $6.1M | +28.7% |
| Investing Cash Flow | -$16.3M | +53.8% |
| Financing Cash Flow | $97.8M | +99.0% |
| Free Cash Flow | $25.6M | +93.0% |
| -279.4% |
| EPS (Basic) | -$0.42 | -223.1% |
| EPS (Diluted) | -$0.42 | -223.1% |